3-iodobenzylguanidine has been researched along with Cardiomyopathy, Chagas in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Camargo, GC; de Almeida, SA; de Brito, ASX; de Holanda, MT; de Sousa, AS; Glavam, AP; Mendes, FSNS; Moll-Bernardes, RJ; Oliveira, RS; Pinheiro, MVT; Rosado-de-Castro, PH; Sangenis, LHC; Siqueira, FPR | 1 |
| Barizon, GC; Gadioli, LP; Murta Junior, LO; Schmidt, A; Simões, MV | 1 |
| Morillo, CA; Velasco, A | 1 |
| Braga, DS; Dumont, SM; Freitas, SS; Marino, VSP; Moreira, MDCV; Mota, LDG | 1 |
| Antloga, CM; Bromberg-Marin, G; Maciel, BC; Marin-Neto, JA; Pazin-Filho, A; Pintya, AO; Sarabanda, AV; Simões, MV | 1 |
1 review(s) available for 3-iodobenzylguanidine and Cardiomyopathy, Chagas
| Article | Year |
|---|---|
Chagas heart disease: A contemporary review.
Topics: 3-Iodobenzylguanidine; Animals; Arrhythmias, Cardiac; Chagas Cardiomyopathy; Chagas Disease; Electrocardiography; Heart; Heart Diseases; Humans; Insect Vectors; Insecta; Prognosis; Radionuclide Imaging; Risk; Treatment Outcome; Trypanosoma cruzi | 2020 |
1 trial(s) available for 3-iodobenzylguanidine and Cardiomyopathy, Chagas
| Article | Year |
|---|---|
Relation of regional sympathetic denervation and myocardial perfusion disturbance to wall motion impairment in Chagas' cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adult; Analysis of Variance; Chagas Cardiomyopathy; Female; Heart; Humans; Male; Middle Aged; Myocardial Contraction; Probability; Radionuclide Imaging; Reference Values; Regional Blood Flow; Sensitivity and Specificity; Statistics, Nonparametric; Sympathectomy; Sympathetic Nervous System; Thallium Radioisotopes; Ventricular Dysfunction, Left | 2000 |
3 other study(ies) available for 3-iodobenzylguanidine and Cardiomyopathy, Chagas
| Article | Year |
|---|---|
Autonomic denervation, myocardial hypoperfusion and fibrosis may predict ventricular arrhythmia in the early stages of Chagas cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Autonomic Denervation; Chagas Cardiomyopathy; Chagas Disease; Contrast Media; Coronary Artery Disease; Death, Sudden, Cardiac; Fibrosis; Gadolinium; Humans; Myocardial Ischemia; Ventricular Premature Complexes | 2023 |
Relationship between microvascular changes, autonomic denervation, and myocardial fibrosis in Chagas cardiomyopathy: Evaluation by MRI and SPECT imaging.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Autonomic Denervation; Autonomic Nervous System; Chagas Cardiomyopathy; Female; Fibrosis; Heart; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Microcirculation; Middle Aged; Myocardial Perfusion Imaging; Myocardium; Radiopharmaceuticals; Risk Factors; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2020 |
Sympathetic Dysautonomia in Heart Failure by 123I-MIBG: comparison between Chagasic, non-Chagasic and heart transplant patients.
Topics: 3-Iodobenzylguanidine; Adult; Chagas Cardiomyopathy; Cross-Sectional Studies; Female; Heart Failure; Heart Transplantation; Humans; Male; Middle Aged; Primary Dysautonomias; Radionuclide Imaging; Radiopharmaceuticals | 2018 |